PharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc.

Rhea-AI Summary

PharmChem (OTC: PCHM) announced that shareholders have approved its acquisition by Alcohol Monitoring Systems, Inc. at a special meeting held on August 27, 2025. According to the agreement terms, PharmChem shareholders will receive $3.75 per share in cash consideration.

The transaction is expected to be finalized at the close of business on August 28, 2025. The company has provided contact information for shareholders with specific questions regarding the acquisition.

Positive

• Cash consideration of $3.75 per share for shareholders
• Quick closing timeline with clear execution date

Negative

• Company will be delisted from OTC markets following acquisition

News Market Reaction – PCHM

+1.08%

1 alert

+1.08% News Effect

On the day this news was published, PCHM gained 1.08%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FORT WORTH, Texas, Aug. 27, 2025 /PRNewswire/ -- PharmChem, Inc. ("PharmChem" or the "Company") (OTC: PCHM) is pleased to announce that its acquisition by Alcohol Monitoring Systems, Inc., was approved by shareholders at today's special meeting. Per the agreement, shareholders of PharmChem will receive $3.75 per share in cash upon final closing.

The Company expects the consummation of the transaction to be effective at the close of business on Thursday, August 28, 2025.

If shareholders have further, specific questions, please email our CFO Shana Veale at sveale@pharmchem.com and we will set up a call.

Tim Eriksen
Chairman of the Board

About PharmChem, Inc.

PharmChem, Inc. ("PharmChem") (OTC: PCHM), headquartered in Fort Worth, TX, is the manufacturer and sole source provider of the PharmChek® Drugs of Abuse Sweat Patch.

Safe Harbor for Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933 ("Forward-looking Statements"), which are subject to the "safe harbor" created by these Sections. Forward-looking statements are statements about future financial results, future products or services and www.pharmchem.com other events that have not yet occurred. These forward-looking statements contain words such as, but not limited to, "expect", "anticipate", "estimate", "believe", "will", "may" or "might". Investors should be aware that actual results may differ materially from our expressed expectations because of risks and uncertainties about the future. We will not necessarily update the information in this letter if any forward-looking statement later turns out to be inaccurate.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pharmchem-inc-announces-shareholder-approval-of-acquisition-by-alcohol-monitoring-systems-inc-302540192.html

SOURCE PharmChem, Inc.

FAQ

What is the acquisition price per share for PharmChem (PCHM) shareholders?

PharmChem shareholders will receive $3.75 per share in cash upon the closing of the acquisition.

When will the PharmChem (PCHM) acquisition by Alcohol Monitoring Systems close?

The acquisition is expected to close at the end of business on August 28, 2025.

Who is acquiring PharmChem (PCHM)?

Alcohol Monitoring Systems, Inc. is acquiring PharmChem.

How can PharmChem shareholders get more information about the acquisition?

Shareholders with specific questions can email CFO Shana Veale at sveale@pharmchem.com to set up a call.